Clinical Trial

SakuraBead Used as Resorbable Embolic for Genicular Artery Embolization

Study acronym: SURE
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
An open label, prospective, two-arm, multicenter, randomized controlled trial comparing SakuraBead genicular artery embolization (GAE) with a control (corticosteroid injection).
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2024-08-09; most recent amendment 2026-03-16.
Status change: Recruiting → Active, Not Recruiting 2026-03-16
Status change: Not Yet Recruiting → Recruiting 2024-11-06
Trial Details
NCT Number NCT06550024
Lead Sponsor CrannMed
Conditions Osteo Arthritis Knee, Joint Diseases, Musculoskeletal Diseases, Rheumatic Diseases, Arthritis, Osteoarthritis
Enrollment 89 participants
Start Date 2024-11-28
Primary Completion 2026-10 (estimated)
Study Completion 2028-10 (estimated)
Updated on ClinicalTrials.gov 2026-03-18